Daniel Fitzgerald is a prominent Geneva Academic Leader and the Co-Founder and CEO of Geneva Biotech and Halo Therapeutics. With a strong background in biotechnology and pharmaceuticals, he is dedicated to advancing innovative solutions in healthcare. His leadership focuses on fostering collaboration between academia and industry to drive research and development. Daniel is committed to improving patient outcomes through cutting-edge technology and strategic partnerships.